| #250 |
Allan Weingarten |
Intervet |
5 |
| #250 |
Dennis E. Egan |
Telcordia Technologies |
5 |
| #250 |
Jimmy M. Fountoulakis |
Merck |
5 |
| #250 |
Li-Wei Tu |
AT&T |
5 |
| #250 |
Mohammed El-Sherbeini |
Merck |
5 |
| #250 |
Richard D. Lanam |
Engelhard |
5 |
| #250 |
Ira R. Berry |
Pharmacaps |
5 |
| #250 |
David Contract |
Msd Consumer Care |
5 |
| #250 |
Anthony M. Gleason |
ExxonMobil |
5 |
| #250 |
Pam Kornfeld |
American Express |
5 |
| #250 |
Kazumitsu KAWAKAMI |
L'Oreal |
5 |
| #250 |
Rebecca Mason |
Comcast |
5 |
| #250 |
Russell R. Ferlita |
Merck |
5 |
| #250 |
Richard S. Auda |
ExxonMobil |
5 |
| #250 |
Nikolaos Melissaris Papanikolaou |
— |
5 |
| #250 |
Kevan R. Thompson |
Merck |
5 |
| #250 |
Henry M. Nixon, Jr. |
Mahaffy & Harder Engineering |
5 |
| #250 |
Marvin M. Goldenberg |
Merck |
5 |
| #250 |
William A. Piegari |
— |
5 |
| #250 |
Brendan Magrab |
— |
5 |
| #250 |
Hugh K. McGuire |
Disney |
5 |
| #250 |
Anton J. Wild |
— |
5 |
| #250 |
William Bartok |
ExxonMobil |
5 |
| #250 |
Jeffrey H. Siegell |
ExxonMobil |
5 |
| #250 |
George G. Hazen |
Merck |
5 |
| #250 |
Michelle Victoria Nahum-Albright |
Elizabeth Arden |
5 |
| #250 |
Stanley A. Zadrozny |
Verizon |
5 |
| #250 |
David WEINBERG |
Merck |
5 |
| #250 |
Jeffrey H. Toney |
MIT |
5 |
| #250 |
Joseph A. Borkowski |
Merck |
5 |
| #250 |
Wendy S. Horn |
Merck |
5 |
| #250 |
Ramaswamy Iyer |
JPMorgan Chase |
5 |
| #250 |
Albert E. Siecke |
Warner-Lambert Company |
5 |
| #250 |
James M. Spitler |
Schering |
5 |
| #250 |
Hong Wen |
Pfizer |
5 |
| #250 |
Rick Reimlinger |
Google |
5 |
| #250 |
Arthur Kressner |
Consolidated Edison Company Of New York |
5 |
| #250 |
Gerald H. Newman |
ExxonMobil |
5 |
| #250 |
Alexandre Ambrogelly |
Merck |
5 |
| #290 |
Jean-Francois Marcoux |
MIT |
4 |
| #290 |
Huijun Wang |
Merck |
4 |
| #290 |
Don Fishbein |
Savient Pharmaceuticals |
4 |
| #290 |
W. Robert Hatfield |
Engelhard |
4 |
| #290 |
Jack T. Inamorato |
Colgate-Palmolive |
4 |
| #290 |
Neil D. Potter |
Citigroup Global Markets |
4 |
| #290 |
Mark A. Hartney |
MIT |
4 |
| #290 |
Stephen L. De Felice |
— |
4 |
| #290 |
Bryce Salvador |
— |
4 |
| #290 |
Lelia M. Fuentes |
Merck |
4 |
| #290 |
Joel R. Zingerman |
Merck |
4 |